Humacyte

We're hiring — explore open roles below and apply in a few clicks.

0 followers

humacyte.com/

Location

Headquarters: Morrisville, North Carolina, United States, North America

Region: North Carolina

Country: US

Continent: North America

About

Humacyte is a biotechnology company developing bioengineered, universally implantable human tissues intended for regenerative medicine applications. The company’s platform transforms human cells into off-the-shelf tissues designed to repair or replace damaged structures across a broad range of diseases and injuries, with a focus on vascular and organ systems. Headquartered in Durham, North Carolina, Humacyte conducts research, development, and manufacturing of tissue-based products and has FDA-regulated programs, including products like Symvess. The organization emphasizes progressing regenerative biologics from discovery through clinical trials to potential commercial use.

Humacyte is a biotechnology company developing bioengineered, universally implantable human tissues for regenerative medicine. Its primary product, human acellular vessels (HAVs), is designed to treat vascular conditions such as trauma and hemodialysis access needs. The company focuses on manufacturing these off-the-shelf biological products for clinical and commercial use.

Legal Name:

Humacyte, Inc.

Founded:

2004

Company Type:

for_profit

Operating Status:

active

Industries

Primary Industry: Business Services

Business ServicesManagement ConsultingResearch & DevelopmentPharmaceuticalsChemicals & Related ProductsTest & Measurement Equipment

Funding & Financials

Funding Stage:

Public Company

Total Funding:

864100000

Revenue:

under-1m

IPO Status:

ipo

Stock Symbol:

NASDAQ:HUMA

Stock Exchange:

nasdaq

Investors

Avenue Capital GroupFresenius Medical CareOrbiMedAlexandria Venture InvestmentsMorgan Creek Capital ManagementUBS O'ConnorMonashee Investment ManagementSilicon Valley BankCalifornia Institute for Regenerative Medicine

Founders

Juliana L. Blum

Laura Niklason

Leadership

Laura Niklason — Founder

Juliana L. Blum — Co-Founder and Executive Advisor

Juliana L. Blum — Co-Founder and Executive Vice President of Corporate Development

Shamik Parikh — CMO

Laura Niklason — President and Chief Executive Officer

Dale A. Sander — Chief Financial Officer and Chief Corporate Development Officer

B.J. Scheessele — Chief Commercial Officer

Rick McElheny — Senior Vice President of Business Development

Brady Dougan — board_member

Technology Stack

DNSSECCloudflare CDNCloudflarejQuery CDNCloudflare HostingMicrosoftRuby on Rails TokenEnvoyAWS Global AcceleratorMicrosoft Azure

Products

Acellular Tissue Engineered Vessel (ATEV™): A bioengineered vessel designed to replace or repair damaged vascular tissue in various clinical applications including dialysis access, peripheral artery disease, coronary artery bypass, and pediatric heart surgery.